BRBR — BellRing Brands
Premier Protein didn’t disappear. The margin did. That’s why I’m interested.
BellRing owns Premier Protein and Dymatize. Demand has held up way better than the stock makes it look. Profitability has not. That is the whole setup: is this an ugly temporary margin and inventory problem, or is the business structurally worse than I think?
Premier Protein did not disappear. The margin did. That is basically the whole BellRing thesis, and somehow I have spent an unreasonable amount of time thinking about protein shakes because of it.
Why I care about this one
My bet is that the market is treating the current margin and inventory mess as more permanent than it actually is. Premier Protein still has real category strength, demand is holding up, and even a partial profitability recovery can do a lot from this depressed equity value.
Q3 FY2026 sales were $570.4M, up 4%, while adjusted EBITDA was $78.3M and profitability remained under heavy pressure from input costs and inventory actions. Management’s FY2026 guide is $2.335B–$2.375B of sales and $275M–$295M of adjusted EBITDA. This is not a clean business right now. That is kind of why the setup exists.
Fiscal Q3 2026
Primary sources: Q3 FY2026 earnings release — SEC ↗ · Q3 supplemental ↗ · Full Mostly Nothing scenario model ↗
The starter is no longer hypothetical. I bought about $5,000 of BRBR at roughly $7.63 on Sep. 29, giving me 655.308 shares and an approximately 1.6% position. Nothing about the thesis or scenario model changed because I clicked buy. The next dollar still needs evidence.
My position
What I actually bought and sold.
| Date | Type | Account | Dollars | Shares | Price | Return now* |
|---|---|---|---|---|---|---|
| Sep 29, 2026 | Buy | Taxable | $5,000 | 655.308 | $7.63 | +3.7% |
*Return now uses the latest available quote for buys and reinvestments. Sales and fees show “—”.
Valuation & scenario math
There is no tidy P/E band because the earnings base is depressed. I put the starter on Sep. 29, and the hard 3% asymmetry cap stays in place unless the evidence changes dramatically. Current price, weight and P/L belong in the live snapshot above.
Recovery scenario + sizing
The starter is real now: 655.308 shares at about $7.63, roughly $5K and about 1.6% of invested assets at the post-trade snapshot. Another dollar needs margin repair, inventory cleanup and deleveraging. There is still a hard 3% asymmetry cap.
This is a turnaround and margin-recovery model. I am not pretending today's P/E tells me much when the earnings base is the broken part. The question is what the equity looks like if demand holds, margins partially recover and leverage comes down.
| Case | What has to be true | Target range | Annualized return from today |
|---|---|---|---|
| Bear | 2031 revenue ~$2.4B, ~12% EBITDA margin, 6x EV/EBITDA, leverage stays heavy. | $5.00–$8.00 center ~$6.30 | -4.5% |
| Base | 2031 revenue ~$2.9B, ~16% EBITDA margin, 8x EV/EBITDA, debt comes down. | $24–$33 center ~$28 | +29.4% |
| Bull | 2031 revenue ~$3.3B, ~19% EBITDA margin, 10.5x EV/EBITDA, strong deleveraging. | $45–$70 center ~$57 | +48.9% |
Returns use the current quote and the time remaining to Sep 24, 2031. The scenario targets stay fixed until the underwriting changes.
Capital allocation
The financing runway exists. The sequencing is what annoys me.
Demand is still there and the debt runway extends into 2030, which matters. Margin repair has not happened yet. The $133.1M of repurchases while inventory and leverage were getting more important makes the capital sequencing harder to defend, even though the buybacks did reduce shares.
Stage-relative, not some objective rating-agency grade. The number is there to force the judgment into the open. See the rubric →
What management is actually doing with the cash
Management does not get a free pass here. They bought back a lot of stock at prices that look terrible now while inventory and leverage became more important. Maybe the decision was rational with the information they had. Fine. It still raises the bar. I would much rather see debt reduction, working-capital cleanup and reinvestment beat aggressive buybacks until the business is normal again.
What I’m doing with the next dollar
The starter exists. Great. That does not mean every red day gets another buy. I want margin stabilization, inventory cleanup, durable Premier Protein demand and deleveraging. Until then, about $5K is enough.
What can break this
Debt, third-party manufacturing, inventory, input costs, customer concentration, a new CEO and the possibility margins do not mean-revert. Also, BellRing repurchased a lot of stock far above today’s price, which absolutely belongs in the capital-allocation file even if hindsight alone does not prove the decision was bad.
If Premier Protein loses category strength, margins fail to recover for structural reasons, inventory/supply-chain issues keep compounding, or leverage becomes the story, the cheap-looking valuation is probably just cheap for a reason.
I finally did something and put about $5K in on Sep. 29. Now the much less exciting job is waiting to see if the business gives me a reason to do anything else.
The evidence I’m watching
Gross margin stabilizes and starts rebuilding, Premier Protein demand and distribution stay healthy, inventory normalizes, FY2027 guidance gives me a credible earnings-recovery path, and free cash flow goes to deleveraging before another big repurchase wave.
Margins stay stuck near the depressed level, promotions become permanently necessary to hold volume, inventory stays elevated, leverage does not fall, or the new CEO chooses buybacks and growth spending before the balance sheet is cleaned up.